Free express shipping over $999 · Verified pharmaceuticals · Discreet packaging worldwide
OnlineMeds onlinemeds.org
Account Cart
Skip to enquiry form
Prescription only medicine

Bdparp 150 mg Tablets

Olaparib 150 mg · Generic equivalent of Lynparza

Bdparp 150 mg Tablets is a trusted medication containing Olaparib, designed for personal use under the guidance of a healthcare professional. Available for prescription-based international supply with discreet worldwide delivery.

Active ingredient
Olaparib
Strength
150 mg
Form
Tablet
Manufacturer
BDR Pharmaceuticals Intl. Pvt. Ltd.
Made in
India
Prescription
Required
Commonly used forProstate Cancer

Generic equivalent of Lynparza — up to 80% less than the branded price

Our oncology team reviews every request personally and responds within 24 hours.
Verified pharmacy Genuine medication Tracked shipping Medically reviewed by A. Srinivasan
Licensed Pharmacy Trust & safety
Licensed Manufacturers Every medicine from a licensed manufacturer
Dedicated Oncology Team Doctor + pharmacist review every order before dispatch
Worldwide Delivery UK · US · AU · EU · NZ — tracked and insured
About this medicine

What is Bdparp 150 mg Tablets?

Olaparib is a targeted medicine taken by mouth for cancers that have a weakness in DNA repair — most often those with a BRCA1 or BRCA2 mutation. It is used as maintenance treatment for ovarian cancer after chemotherapy, for HER2-negative breast cancer with an inherited BRCA mutation, for BRCA-mutated pancreatic cancer, and for prostate cancer with certain DNA-repair mutations.

It is a PARP inhibitor: it blocks an enzyme cancer cells with faulty BRCA rely on to patch up their DNA, so those cells accumulate damage and die while normal cells, which have working BRCA, cope. Genetic testing of the tumour or blood is needed before it is prescribed for most uses.

Olaparib comes as 100 mg and 150 mg tablets and as 50 mg capsules. The two forms are absorbed differently and have different doses — they must never be swapped milligram for milligram. It is taken twice a day, continuously. Olaparib is a prescription-only medicine; a valid prescription must be provided at checkout.

How it works

How does Olaparib work?

Cells constantly repair small breaks in their DNA, using an enzyme called PARP for the quick fixes and the BRCA proteins for the more serious double-strand breaks. Cancer cells with a BRCA mutation have lost the second system and lean entirely on PARP. Olaparib blocks PARP and traps it on the DNA, so small breaks turn into double-strand breaks that the cell cannot mend — and it dies. Normal cells still have working BRCA, so they repair the damage and survive. This 'two hits' idea is called synthetic lethality, and it is why a genetic test matters: without the DNA-repair weakness the drug has much less to work with.

PARP trapping

Olaparib binds PARP1/2 and holds the enzyme on damaged DNA, blocking single-strand break repair.

Breaks accumulate

Trapped PARP complexes stall replication forks, converting single-strand lesions into double-strand breaks.

Synthetic lethality

Cells lacking BRCA-mediated homologous recombination cannot repair those breaks and undergo apoptosis; HR-competent normal cells survive.

Uses

What is Olaparib used for?

Ovarian, fallopian tube or primary peritoneal cancer — maintenance

After response to platinum chemotherapy; first-line in BRCA-mutated or (with bevacizumab) HRD-positive disease, or recurrent platinum-sensitive disease.

FDA EMA CDSCO
HER2-negative breast cancer with germline BRCA mutation

High-risk early disease after chemotherapy (adjuvant, one year) or metastatic disease after chemotherapy.

FDA EMA CDSCO
Metastatic pancreatic cancer with germline BRCA mutation — maintenance

After at least 16 weeks of platinum chemotherapy without progression.

FDA EMA
Metastatic castration-resistant prostate cancer with HRR gene mutations

After enzalutamide or abiraterone; or with abiraterone in BRCA-mutated disease.

FDA EMA

Only your oncologist can determine whether this medicine is right for your diagnosis. The above is for information only.

Dosage

How to take Bdparp 150 mg Tablets

Your oncologist will prescribe your exact dose. The right dose for you depends on your weight, kidney and liver function, and — for some medicines — your genetic test results.

Always take exactly as prescribed. Do not change your dose or stop taking this medicine without speaking to your doctor first, even if you feel well.

Missed a dose? Skip a missed dose and take the next one at the usual time. Do not double up.

With food? Tablets: with or without food. Capsules: at least one hour after food, and no food for two hours afterwards. Swallow whole; do not crush or chew. Avoid grapefruit and Seville oranges.

Important safety information

Safety & warnings

Please read this section before taking Bdparp 150 mg Tablets and discuss any concerns with your oncologist.

Common side effects

Side effects affect some people, not everyone. Most are manageable — let your treatment team know about anything that concerns you.

  • Nausea (usually settles after the first weeks)
  • Tiredness (fatigue)
  • Anaemia (low red cells)
  • Vomiting, reduced appetite, taste changes
  • Diarrhoea
  • Headache, dizziness
  • Low white cells, low platelets
  • Cough, breathlessness
  • Raised creatinine (a lab effect)

Contact your doctor immediately if you notice:

  • Severe tiredness, breathlessness, pale skin Contact your team — anaemia is common and may need a dose pause or transfusion.
  • Persistent low blood counts, unusual bruising, or infections that keep recurring Tell your team — rarely olaparib is linked to myelodysplasia or acute myeloid leukaemia; counts are checked monthly and a marrow test is done if they do not recover.
  • New or worsening breathlessness, dry cough, fever Seek urgent review — lung inflammation (pneumonitis) is rare but reported.
  • Chest pain, sudden breathlessness, calf pain or swelling Seek emergency care — blood clots occur more often, particularly in prostate cancer.
  • Nausea or vomiting that stops you eating and drinking Contact your team; anti-sickness medicine and a dose change usually help.

Important: tell your doctor about these medicines

Taking Olaparib with certain other medicines can be dangerous. Always tell every doctor, dentist, and pharmacist about all medicines you are taking.

  • Strong CYP3A inhibitors (ketoconazole, itraconazole, clarithromycin, ritonavir) and grapefruit Major

    Increase olaparib levels.

  • Moderate CYP3A inhibitors (fluconazole, diltiazem, verapamil, erythromycin) Major

    Increase olaparib levels.

  • Strong or moderate CYP3A inducers (rifampicin, phenytoin, carbamazepine, St John's wort, efavirenz) Major

    Reduce olaparib levels and may make it less effective.

  • Other bone-marrow-suppressing medicines Major

    Additive lowering of blood counts.

  • Live vaccines Major

    Safety not established while counts are low.

Pregnancy & breastfeeding

Olaparib can harm an unborn baby. It should not be used in pregnancy, and women who could become pregnant should use effective contraception during treatment and for at least six months after the last dose. Hormonal contraceptives may be less reliable in hormone-sensitive cancers — a barrier method is usually advised as well.

Do not breastfeed during treatment or for one month after the last dose.

Olaparib may reduce fertility. Discuss fertility preservation before starting if relevant.

For full prescribing information see: FDA prescribing information: Lynparza (olaparib) — DailyMed

Storage

How to store Bdparp 150 mg Tablets

Temperature

Store below 30°C (86°F).

Light & moisture

Keep in the original blister or bottle.

Keep away from children

Keep out of the sight and reach of children.

Safe handling

Anticancer medicine: swallow whole, do not crush or open; wash hands after handling. Return unused medicine to a pharmacy.

Travelling

Carry in original packaging with your prescription and an oncologist's letter. Keep tablets and capsules clearly separate if you have both — they are different doses.

Reviewed for accuracy

Medically reviewed content

A. Srinivasan

A. Srinivasan

B.Pharm, M.Pharm

A. Srinivasan is a licensed clinical pharmacist with 24 years of experience. He holds a B.Pharm and M.Pharm from University of Madras. At OnlineMeds, he reviews medicine and health content to help ensure it is accurate, evidence-based, and easy to understand.

Our commitment to you

How we support oncology patients

We understand that accessing the right cancer medicine can feel overwhelming. Here is what you can expect from us.

Personal oncology support

Every enquiry is reviewed by our oncology doctor and pharmacist team — not an automated system.

Genuine, verified medicine

Sourced exclusively from licensed pharmaceutical manufacturers. Every batch is traceable from origin to your door.

Prescription checked before dispatch

We verify every prescription with our internal medical team. No shortcuts, no exceptions.

Cold-chain logistics

Temperature-sensitive medicines shipped with appropriate packaging to maintain integrity.

Discreet, plain packaging

No pharmacy branding or product name on the outer packaging.

Up to 80% less than branded

Generic oncology medicines contain the same active ingredient as the originator brand — at a fraction of the cost.

FAQ

Frequently asked questions

Is Olaparib the same as Lynparza?

Olaparib is the active ingredient in Lynparza. A generic Olaparib medicine contains the same active ingredient at the same strength and is taken the same way — the main difference is cost. Always use it as prescribed by a licensed medical professional.

Why do I need a BRCA or HRD test before Bdparp 150 mg Tablets?

Olaparib works by exploiting a weakness in DNA repair. Tumours with a BRCA1/2 mutation — or a broader "homologous recombination deficiency" — have that weakness; most others do not, and the drug helps far less. Your oncologist will have tested your tumour or blood before prescribing.

[2] NCI Drug Information: Olaparib

Are the tablets and capsules interchangeable?

No. The tablets (100 mg, 150 mg) and the older capsules (50 mg) are absorbed differently: 300 mg of tablets is the equivalent of 400 mg of capsules. Never substitute one for the other milligram for milligram, and tell your pharmacist which form you have been prescribed.

[1] FDA prescribing information: Lynparza (olaparib) — DailyMed

Is Bdparp 150 mg Tablets chemotherapy?

No. It is a targeted therapy that blocks one repair enzyme. It does lower blood counts — especially haemoglobin — so blood tests are monthly, but hair loss and severe sickness are not typical, and the nausea usually eases after the first few weeks.

[4] Macmillan Cancer Support: Olaparib (Lynparza)

How long will I take Bdparp 150 mg Tablets?

It depends on the use: one year as adjuvant treatment for early breast cancer; up to two years as first-line ovarian maintenance if there is no sign of disease; otherwise for as long as it is working and tolerated. Your oncologist will tell you the plan.

[3] EMA: Lynparza — European public assessment report

What is the risk of a second blood cancer?

A small number of people treated with PARP inhibitors — well under 2% in the studies — have developed myelodysplasia or acute myeloid leukaemia, usually after prior platinum chemotherapy. Monthly blood counts are the safeguard; counts that do not recover after a pause are investigated. Discuss this with your oncologist so it is in proportion.

[1] FDA prescribing information: Lynparza (olaparib) — DailyMed

Is Bdparp 150 mg Tablets the same as Lynparza?

Bdparp 150 mg Tablets contains the same active ingredient, olaparib, at the same strength and in the same form as the corresponding Lynparza product. Generic medicines must meet the same regulatory standards for quality, safety and effectiveness. Used as prescribed by a licensed medical professional.

[3] EMA: Lynparza — European public assessment report

Why has my creatinine gone up?

Olaparib reduces how much creatinine the kidneys secrete into urine, so the blood level rises without the kidneys being damaged. Your team knows this and uses other measures if needed.

[1] FDA prescribing information: Lynparza (olaparib) — DailyMed

Do I need a prescription to order Bdparp 150 mg Tablets?

Yes. Olaparib is prescription-only. Upload your oncologist's prescription at checkout; our pharmacist team reviews it before dispatch. Used as prescribed by a licensed medical professional.

Sources

References

  1. 1. FDA prescribing information: Lynparza (olaparib) — DailyMed. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=lynparza U.S. National Library of Medicine. Accessed 13 Sep 2026.
  2. 2. NCI Drug Information: Olaparib. https://www.cancer.gov/about-cancer/treatment/drugs/olaparib National Cancer Institute. Accessed 13 Sep 2026.
  3. 3. EMA: Lynparza — European public assessment report. https://www.ema.europa.eu/en/medicines/human/EPAR/lynparza European Medicines Agency. Accessed 13 Sep 2026.
  4. 4. Macmillan Cancer Support: Olaparib (Lynparza). https://www.macmillan.org.uk/cancer-information-and-support/treatments-and-drugs/olaparib Accessed 13 Sep 2026.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional — specifically your oncologist — before starting, changing, or stopping any medication. Information is based on NDA #208558 (tablets) / #206162 (capsules), NCI Drug Information, and NHS patient information.
Editorial policy Privacy policy Terms & conditions
Shopping cart
Close
Shop
0 items Cart
My account